
Carlos Sánchez Solimán
Carlos Sánchez Solimán is the director of the Programa de Medicamentos de Alto Costo (PMAC) in the Dominican Republic, recently in the news for addressing concerns raised by the Comité de Pacientes de Artritis Reumatoides (Copar-Lea) regarding the long waiting list for patients requiring high-cost medications. He acknowledged the existence of a waiting list and emphasized the program's commitment to providing high-quality treatment to over 1,400 current users while also highlighting the substantial financial investments made in the program since its inception.
Not in the pool (under ¢1).
Recent news mentions
Carlos Sánchez Solimán is the director of DAMAC who met with Elías Báez to discuss medication coverage issues.
Dida denuncia que las ARS no adquieren los fármacos en la Dirección Medicamentos de Alto Costo
Carlos Sánchez Solimán, the director of the PMAC, acknowledged the existence of a waiting list that they intend to address.
Solo ocho pacientes de los 132 en lista de espera están activos en el programa